blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP2292619

EP2292619 - Purine derivatives for use as adenonsin A-2A receptor agonists [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  24.05.2013
Database last updated on 05.10.2024
Most recent event   Tooltip24.05.2013Application deemed to be withdrawnpublished on 26.06.2013  [2013/26]
Applicant(s)For all designated states
Novartis AG
Lichtstrasse 35
4056 Basel / CH
[2011/10]
Inventor(s)01 / Fairhurst, Robin Alec
Novartis Horsham Research Center Wimblehurst Road
Horsham, Sussex RH12 5AB / GB
02 / Taylor, Roger John
Novartis Horsham Research Center Wimblehurst Road
Horsham, Sussex RH12 5AB / GB
03 / Singh, Paul
Novartis Horsham Research Center Wimblehurst Road
Horsham, Sussex RH12 5AB / GB
 [2011/10]
Representative(s)von Sprecher, Georg
Novartis Pharma AG
Patent Department
4002 Basel / CH
[N/P]
Former [2011/10]von Sprecher, Georg
Novartis Pharma AG Patent Department
4002 Basel / CH
Application number, filing date10178514.521.10.2005
[2011/10]
Priority number, dateGB2004002355122.10.2004         Original published format: GB 0423551
GB2005001461915.07.2005         Original published format: GB 0514619
[2011/10]
Previously filed application, dateWO2005EP1134421.10.2005
[2011/10]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP2292619
Date:09.03.2011
Language:EN
[2011/10]
Search report(s)(Supplementary) European search report - dispatched on:EP28.01.2011
ClassificationIPC:C07D473/16, C07D473/32, C07D473/40, A61K31/52, A61P29/00
[2011/10]
CPC:
C07D473/32 (EP,US); C07D473/34 (KR); A61K31/52 (KR);
A61P11/00 (EP); A61P11/06 (EP); A61P11/08 (EP);
A61P29/00 (EP); A61P37/00 (EP); A61P43/00 (EP);
C07D473/16 (EP,KR,US); C07D473/40 (EP,US) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2011/10]
Extension statesHR09.09.2011
TitleGerman:Purinderivate und ihre Verwendung als Adenosin A-2A Rezeptor Agonisten[2011/10]
English:Purine derivatives for use as adenonsin A-2A receptor agonists[2011/10]
French:Derivés de purin et leurs utilisation comme agonists d'adenosin-A2A-récepteur[2011/10]
Examination procedure01.09.2011Amendment by applicant (claims and/or description)
09.09.2011Examination requested  [2011/42]
25.06.2012Despatch of a communication from the examining division (Time limit: M06)
08.01.2013Application deemed to be withdrawn, date of legal effect  [2013/26]
12.02.2013Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2013/26]
Parent application(s)   TooltipEP05797944.5  / EP1805181
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued (EP20050797944) is  18.06.2009
Fees paidRenewal fee
24.01.2011Renewal fee patent year 03
24.01.2011Renewal fee patent year 04
24.01.2011Renewal fee patent year 05
12.11.2010Renewal fee patent year 06
11.10.2011Renewal fee patent year 07
11.10.2012Renewal fee patent year 08
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[AD]EP1221444  (EISAI CO LTD [JP]);
by applicantUS3714357
 EP0021973
 EP0147716
 EP0424021
 WO9219594
 US5171744
 JPH0525045B
 WO9318007
 WO9319749
 WO9319750
 WO9319751
 US5451700
 WO9818796
 WO9916766
 WO9964035
 WO9965895
 WO0000531
 WO0066558
 WO0066559
 WO0075114
 US6166037
 WO0104118
 WO0113953
 WO0142193
 WO0183462
 WO0194368
 WO0200679
 WO0200652
 WO0210143
 WO0212266
 US2002055651
 WO0242298
 WO02051841
 WO02053564
 WO02066422
 WO02070490
 WO02076933
 WO02088167
 WO02100879
 WO03000840
 WO03024439
 WO03033495
 WO03035668
 WO03039544
 WO03042160
 WO03042164
 WO03048181
 WO03053966
 WO03062259
 WO03064445
 WO03072592
 WO03072539
 WO03082280
 WO03082787
 WO03086294
 WO03087094
 WO03091204
 WO03099764
 WO03099807
 WO03101932
 WO03104195
 WO03104204
 WO03104205
 WO2004000814
 WO2004000839
 WO2004005229
 WO2004005258
 WO2004005285
 WO2004016601
 WO2004016578
 WO2004018429
 WO2004018450
 WO2004018451
 WO2004018457
 WO2004018465
 WO2004018431
 WO2004018449
 WO2004018422
 WO2004018425
 WO2004019935
 WO2004019944
 WO2004019945
 WO2004022547
 WO2004026248
 WO2004026841
 WO2004026873
 JP2004107299
 WO2004032921
 WO2004033412
 WO2004037805
 WO2004037768
 WO2004037773
 WO2004037807
 WO2004039827
 WO2004039762
 WO2004039766
 WO2004045607
 WO2004045618
 WO2004046083
 DE10261874
 EP1440966
 WO2004066920
 US2004167167
 WO2004074246
 WO2004074812
 EP1460064
 WO2004080964
 WO2004087142
 WO2004089892
 US2004229904
 US2004242622
 WO2004108675
 WO2004108676
 WO2005007908
 WO2005033121
 WO2005040103
 WO2005044787
 US2005133417
 WO2005058867
 WO2005065650
 WO2005066140
 US2005171147
 US2005182091
 US2005182092
 WO2005077361
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.